drugset / Trial / NCT01929876

A Study to Evaluate Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Participants

NCT01929876

Phase 1 Completed 16 enrolled Genentech, Inc.
NaSingle-groupOpen-label

Summary

This open-label, 2-period, fixed sequence, drug interaction study will investigate the effect of co-administration of itraconazole on the pharmacokinetics of cobimetinib in healthy participants. Participants will receive multiple repeating doses of cobimetinib and itraconazole.

Timeline

Start
2013-07
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cobimetinib Small molecule 10 mg Oral
Subject Itraconazole Small molecule 200 mg Oral

Indications

No indication recorded.